Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE ...

Sciences presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial, which is studying ...

周三，花旗开始对吉利德科学公司(NASDAQ:GILD)进行覆盖，给予该股买入评级，并将目标价设定为125美元。这一积极展望基于多个因素，包括公司HIV治疗药物Biktarvy的预期增长，以及即将推出的药物lenacapavir的潜力。

High levels well above the protein-adjusted IC95 [95% inhibitory concentration]. And then at the end of the talk, the ...

The International Research Centre on Artificial Intelligence (IRCAI), an organization under the auspices of UNESCO, in collaboration with Amazon Web Services, Inc. (AWS), today announced the selection ...

As a result, clinical teams don't have access to their most valuable assets when making both current... Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal ...

Phuket is pulling out all the stops in a monumental bid to raise a whopping 290 million baht. The cause? Building a cutting-edge cancer care centre at Vachira Phuket Hospital. This essential ...

Amid fears of an "extremely high level of violent protests," the Brampton Triveni Mandir and Community Centre has cancelled a Life Certificate Event.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...